Anteris Technologies Global Corp. (AVR)
NASDAQ: AVR · Real-Time Price · USD
5.68
+0.17 (3.09%)
At close: Apr 10, 2026, 4:00 PM EDT
5.66
-0.02 (-0.39%)
After-hours: Apr 10, 2026, 7:07 PM EDT
AVR Market Cap
AVR has a market cap or net worth of $523.01 million as of April 10, 2026. Its market cap has increased by 167.37% in one year.
Market Cap
523.01M
Enterprise Value
512.43M
1-Year Change
167.37%
Ranking
Category
Stock Price
$5.68
Market Cap Chart
Since the IPO on October 23, 2017, AVR's market cap has increased from $49.67M to $523.01M, an increase of 952.93%. That is a compound annual growth rate of 32.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 523.01M | 146.35% |
| Dec 31, 2025 | 212.31M | 15.42% |
| Dec 31, 2024 | 183.94M | -20.93% |
| Dec 29, 2023 | 232.62M | 10.90% |
| Dec 30, 2022 | 209.76M | 100.65% |
| Dec 31, 2021 | 104.54M | 525.78% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| STAAR Surgical Company | 1.31B |
| Pulse Biosciences | 1.27B |
| Anbio Biotechnology | 1.19B |
| Kestra Medical Technologies | 1.04B |
| Azenta | 1.02B |
| BioLife Solutions | 953.44M |
| Embecta | 524.10M |
| AngioDynamics | 408.48M |